Elsevier Inc.

SHERPA: Unknown

People

  1. Rusch
    Rusch
  2. Riely
    Riely
  3. Kris
    Kris
  4. Miller
    Miller
  5. Travis
    Travis
  6. Ginsberg
    Ginsberg
  7. Huang
    Huang
  8. Park
    Park
  9. Adusumilli
    Adusumilli
  10. Bains
    Bains

Groups

  1. Solid Tumor Oncology Division (14)
  2. Department of Medicine (13)
  3. Surgery (13)
  4. Thoracic Oncology (12)
  5. Survivorship Research (8)
  6. Center for Pancreatic Cancer Research (4)
  7. Radiology, Department of (4)
  8. Biostatistics Service (3)
  9. Body Imaging Service (3)
  10. Epidemiology and Biostatistics (3)
Search Within
  1. "2011"
  2. "Journal of Thoracic Oncology"
  3. "Journal article"
Formats
  1. Journal Article (28)
Groups
  1. Solid Tumor Oncology Division (14)
  2. Department of Medicine (13)
  3. Surgery (13)
  4. Thoracic Oncology (12)
  5. Survivorship Research (8)
  6. Center for Pancreatic Cancer Research (4)

More Groups

People
  1. Valerie Rusch (9)
  2. Gregory Riely (8)
  3. Mark Kris (7)
  4. Christopher Azzoli (6)
  5. Camelia Sima (5)
  6. Maureen Zakowski (5)

More People

Years
  1. 2011 (28)
Publications
  1. Journal of Thoracic Oncology (28)

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib
    Journal Article

    Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Sima, C. S.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations
    Journal Article

    Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed
    Journal Article

    D'Angelo, S. P.; Kris, M. G.; Pietanza, M. C.; Rizvi, N. A.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy
    Journal Article

    Brevet, M.; Shimizu, S.; Bott, M. J.; Shukla, N.; Zhou, Q.; Olshen, A. B.; Rusch, V.; Ladanyi, M.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Nodal staging in lung cancer: Lymph node location or number?
    Journal Article

    Rusch, V. W.; Giroux, D. J.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Frequency of EGFR and KRAS mutations in lung adenocarcinomas in african americans
    Journal Article

    Reinersman, J. M.; Johnson, M. L.; Riely, G. J.; Chitale, D. A.; Nicastri, A. D.; Soff, G. A.; Schwartz, A. G.; Sima, C. S.; Ayalew, G.; Lau, C.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer
    Journal Article

    Krug, L. M.; Crawford, J.; Ettinger, D. S.; Shapiro, G. I.; Spigel, D.; Reiman, T.; Temel, J. S.; Michelson, G. C.; Young, D. Y.; Hoch, U.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • BRIDGE: An open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer
    Journal Article

    Hainsworth, J. D.; Fang, L.; Huang, J. E.; Karlin, D.; Russell, K.; Faoro, L.; Azzoli, C.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save